interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Colestipol Hydrochloride

Generic competition · all medicines · read 12 November 2026

Is there a generic of Colestipol Hydrochloride, and who makes it?

Colestipol Hydrochloride appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 6 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came between 10.6 and 12.3 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Colestipol Hydrochloride2 dosage-form groups in the Orange Book
6generic makers listed
  1. Colestipol Hydrochloride appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 6 generic makers listed as marketed across them.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Where both are dated, the first generic approval came between 10.6 and 12.3 years after the first brand approval.
  4. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Four or more generic makers listed

Brand listed as marketed: Colestid. 6 generic makers with 6 generic products listed as marketed; the first generic approval is dated 24 October 2006.

19901995200020052010201520202025203006brand 1994Impax Laboratories Inc, first approval 24 October 2006Zydus Pharmaceuticals Usa Inc, first approval 10 March 2022Ani Pharmaceuticals Inc, first approval 10 March 2023Edenbridge Pharmaceuticals Llc, first approval 16 August 2024Riconpharma Llc, first approval 3 December 2024Macleods Pharmaceuticals Ltd, first approval 15 September 2025data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Impax Laboratories Inc24 October 20061
Zydus Pharmaceuticals Usa Inc10 March 20221
Ani Pharmaceuticals Inc10 March 20231
Edenbridge Pharmaceuticals Llc16 August 20241
Riconpharma Llc3 December 20241
Macleods Pharmaceuticals Ltd15 September 20251

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Granule, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Colestid. No generic is listed as marketed (2 generic products listed as discontinued).

1995200020052010201520202025203001brand 1995data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.